NCT02817360 | Heart Diseases
... more >> Diabetes Mellitus, Type 2 Collapse << | Phase 4 | Recruiting | February 2021 | Austria
... more >> Internistische Ordination
Recruiting
Mödling, Niederösterreich, Austria, 2340
Contact: Christian Feinböck, MD +43 2236 869 142 office@dr-feinboeck.at
Contact: Christiane Feinböck +43 2236 869 142 office@dr-feinboeck.at
Sub-Investigator: Egbert Seyfried, MD
Principal Investigator: Christian Feinböck, MD
Klinischen Abteilung für Endokrinologie und Diabetologie MU Graz
Recruiting
Graz, Steiermark, Austria, 8036
Contact: Harald Sourij +43-316-385-80363 ha.sourij@medunigraz.at
Contact: Michael Zink +43-680-128-5120 m.zink@medunigraz.at
Sub-Investigator: Julia Mader, MD Prof
Sub-Investigator: Eva Novak, MD
Sub-Investigator: Caren Sourij, MD
Konventhospital der Barmherzigen Brüder Abteilung für Innere Medizin
Recruiting
Linz, Upper Austria, Austria, 4021
Contact: Martin Clodi, Prof.Dr. martin.clodi@bblinz.at
Principal Investigator: Martin Clodi, Prof.Dr.
Sub-Investigator: Michael Resl, Dr.
Krankenanstalt Rudolfstiftung, 1. Medizinische Abteilung
Recruiting
Vienna, Austria, 1030
Contact: Bernhard Ludvik, Prof.Dr. +43 1 711 65 ext 2107 bernhard.ludvik@wienkav.at
Principal Investigator: Bernhard Ludvik, Prof.Dr.
Sub-Investigator: Eva-Christina Krzizek, Dr.
Sub-Investigator: Johanna Brix, Dr.
Sub-Investigator: Astrid Feder, Dr.
Sub-Investigator: Florian Hoellerl, Dr.
Medical University of Vienna Univ.Clinic for Internal Medicine II Department of Cardiology
Recruiting
Vienna, Austria, 1090
Contact: Martin Huelsmann, Doz.Dr. +43 1 40400 ext 46140 martin.huelsmann@meduniwien.ac.at
Principal Investigator: Martin Huelsmann, Doz.Dr.
Sub-Investigator: Raphael Wurm, Dr.
Univ. Klinik für Innere Medizin III Med. Uni Wien
Recruiting
Vienna, Austria, 1090
Contact: Anton Luger, Prof.Dr. 00 43 1 40400 ext 43100 anton.luger@meduniwien.ac.at
Principal Investigator: Anton Luger, Prof.Dr.
Sub-Investigator: Michael Krebs, Prof.Dr.
Universitätsklinik für Augenheilkunde und Optometrie Medizinische Universität Wien
Recruiting
Vienna, Austria, 1090
Contact: Sonja Prager, Dr. +43 1 40400 ext 79470 sonja.prager@meduniwien.ac.at
Principal Investigator: Sonja Prager, Dr.
Sub-Investigator: Julia Hafner, Dr.
Diabetes & Stoffwechselambulanz Gesundheitszentrum Wien Süd
Recruiting
Vienna, Austria, 1100
Contact: Helmut Brath, OA Dr. +43 1 60122 ext 4264 helmut.brath@wgkk.at
Principal Investigator: Helmut Brath, OA Dr.
3. Med. Abtlg., KH Hietzing mit Neurologischem Zentrum Rosenhügel
Recruiting
Vienna, Austria, 1130
Contact: Rudolf Prager, Prof.Dr. +43 1 80110 ext 2351 rudolf.prager@wienkav.at
Principal Investigator: Rudolf Prager, Prof.Dr.
Sub-Investigator: Slobodan Peric, Dr.
Zentrum für Klinische Studien
Recruiting
Wien, Austria, 1060
Contact: Ursula Hanusch, MD +43 1 266 21 91 dr.hanusch@dieinternistin.com
Contact: Michaela Mauritz +43 1 266 21 91 office@dieinternistin.com
Sub-Investigator: Marita Spak, MD
Netherlands
Maastricht University Medical Center; Dep. Cardiology
Recruiting
Maastricht, Netherlands, 6202
Contact: Hans-Peter Brunner-La Rocca, MD Prof +31 43-3877097 hp.brunnerlarocca@mumc.nl
Contact: Mireille Spanjers +31 43-3877099 m.spanjers@mumc.nl
Sub-Investigator: Nick Marks, MD
Sub-Investigator: Wouter Robaeys, MD
New Zealand
Christchurch Heart Institute
Recruiting
Christchurch, New Zealand, 8140
Contact: Richard Troughton, MD Prof +64 3 364 1063 Richard.Troughton@cdhb.health.nz
Contact: Lorraine Skelton +64 3 364 1063 lorraine.skelton@cdhb@health.nz
Principal Investigator: Richard Troughton, MD Prof Collapse << |
NCT00295542 | Hypertension | Phase 4 | Completed | - | Spain
... more >> Hospital Clinico Universitario
Santiago de Compostela, Spain, 15706 Collapse << |
NCT00741585 | Essential Hypertension
... more >> Cardiovascular Disease
Stroke
Chronic Kidney Disease Collapse << | Phase 4 | Completed | - | Spain
... more >> CS Friol
Friol, Lugo, Spain, 27220
CS Baiona
Baiona, Pontevedra, Spain, 36300
CS Bueu
Bueu, Pontevedra, Spain, 36930
CS A Estrada
La Estrada, Pontevedra, Spain, 26680
CS A Guarda
La Guardia, Pontevedra, Spain, 36780
CS Valmiñor
Nigran, Pontevedra, Spain, 36250
CS Panxón
Nigrán, Pontevedra, Spain, 36340
CS Tomiño
Tomiño, Pontevedra, Spain, 36200
Bioengineering & Chronobilogy Labs., University of Vigo
Vigo, Pontevedra, Spain, 36200
Hospital do Meixoeiro
Vigo, Pontevedra, Spain, 36200
CS Calle Cuba
Vigo, Pontevedra, Spain, 36202
CS A Doblada
Vigo, Pontevedra, Spain, 36205
CS Coia
Vigo, Pontevedra, Spain, 36209
CS Sardoma
Vigo, Pontevedra, Spain, 36214
CS Teis
Vigo, Pontevedra, Spain, 36216
CS Vilaboa
Vilaboa, Pontevedra, Spain, 36141
CS San Roque
Vilagarcía De Arousa, Pontevedra, Spain, 36600
CS Fingoi
Lugo, Spain, 27002
Complexo Hospitalario Universitario de Ourense
Orense, Spain, 32005
CS Lerez
Pontevedra, Spain, 36156 Collapse << |
NCT01669434 | - | - | Completed | - | - |
NCT01715584 | Hypertension | Phase 4 | Recruiting | December 31, 2019 | Canada, Ontario
... more >>
London Health Sciences Centre - Victoria Campus
Recruiting
London, Ontario, Canada, N6A 5W9
Contact: Craig J Railton, MD, PhD 519 685 8500 ext 58525 Craig.Railton@lhsc.on.ca
Principal Investigator: Craig J Railton, MD, PhD
Sub-Investigator: Jonathan Fairbairn, BSc
Sub-Investigator: George Nicoloau, MD
Sub-Investigator: Robert Gros, PhD
Sub-Investigator: Jason Franklin, MD
Sub-Investigator: John Yoo, MD
Sub-Investigator: Kevin Fung, MD
Sub-Investigator: Anthony Nichols, MD
Sub-Investigator: Danielle McNeil, MD Collapse << |
NCT00353652 | - | - | Completed | - | - |
NCT00353652 | Hypertension | Phase 4 | Completed | - | United States, Texas
... more >>
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390 Collapse << |
NCT01867047 | Adverse Effects of Angiotensin... more >>-converting-enzyme Inhibitors
Hypotension Collapse << | Not Applicable | Terminated(Following an interi... more >>m analysis the study team felt that there was enough data that showed no significant difference.) Collapse << | - | United States, North Carolina
... more >>
Duke University
Durham, North Carolina, United States, 27710 Collapse << |
NCT01867047 | - | - | Terminated(Following an interi... more >>m analysis the study team felt that there was enough data that showed no significant difference.) Collapse << | - | - |
NCT00188188 | Systemic Lupus Erythematosus | Phase 4 | Unknown | - | Canada, Ontario
... more >>
University Health Network, Toronto Western Division
Recruiting
Toronto, Ontario, Canada, M5T 2S8
Contact: Anne Cymet, RN 416-603-5800 ext 2895 anne.cymet@uhn.on.ca
Principal Investigator: Robert M Iwanochko, MD, FRCP(C), FACC Collapse << |
NCT00438113 | Atrial Fibrillation | Phase 4 | Completed | - | Canada, Nova Scotia
... more >>
QE II Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3A7 Collapse << |
NCT00684489 | Hypertension | Not Applicable | Completed | - | - |
NCT00980187 | Hypertension
... more >>Type 2 Diabetes Mellitus Collapse << | Phase 4 | Completed | - | Romania
... more >> Cardiology, University and Emergency Hospital
Bucharest, Romania, 050098 Collapse << |
NCT03031834 | Diabetic Autonomic Neuropathy | Phase 4 | Completed | - | - |
NCT01669434 | Hypotension on Induction | Phase 4 | Completed | - | United States, Nebraska
... more >>
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198 Collapse << |
NCT00313547 | Hypertension | Phase 4 | Terminated(Very difficult to r... more >>ecruit patients/slow recruitment(2 patients in nearly 2 years).) Collapse << | - | Canada, Quebec
... more >> Montreal Heart Institute
Montreal, Quebec, Canada, H1T 1C8 Collapse << |
NCT00159692 | Hypertension | Phase 4 | Completed | - | - |
NCT00649441 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00269243 | CABG | Phase 4 | Completed | - | - |
NCT00648011 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00154050 | Arterial Occlusive Diseases | Not Applicable | Completed | - | Germany
... more >> Chemnitz Hospital, Dept. of Internal Medicine I
Chemnitz, Germany, 09313 Collapse << |
NCT00150826 | Ischemic Heart Disease | Phase 4 | Completed | - | United States, Florida
... more >>
University of Florida
Gainesville, Florida, United States, 32610 Collapse << |
NCT00651287 | Hypertension | Phase 4 | Completed | - | Turkey
... more >> Pfizer Investigational Site
Cerrahpasa, Istanbul, Turkey, 34300
Pfizer Investigational Site
Diyarbak R, Turkey, 21280 Collapse << |
NCT01581476 | Type 1 Diabetes | Phase 3 | Completed | - | Australia
... more >> University of Western Australia
Perth, Australia
Canada, Ontario
Hospital for Sick Children
Toronto, Ontario, Canada Collapse << |
NCT00147524 | Menopause
Hyp... more >>ertension Collapse << | Phase 4 | Completed | - | Hungary
... more >> Pfizer Investigational Site
Hodmezovasarhely, Csongrad, Hungary
Pfizer Investigational Site
Budapest, Hungary
Pfizer Investigational Site
Mateszalka, Hungary
Pfizer Investigational Site
Szeged, Hungary
Pfizer Investigational Site
Szombathely, Hungary Collapse << |
NCT00930722 | - | - | Completed | - | - |
NCT00649103 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00649649 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00872235 | Healthy | Not Applicable | Completed | - | India
... more >> Ranbaxy CPU
New Delhi, India, 110 062 Collapse << |
NCT00930722 | - | - | Completed | - | India
... more >> Pfizer Investigational Site
Patna, Bihar, India, 01
Pfizer Investigational Site
Ahmedabad, Gujarat, India, 380 015
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 003
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 051
Pfizer Investigational Site
Ahmedabad, Maharashtra, India, 380 015
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440 015
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440 033
Pfizer Investigational Site
Pune, Maharashtra, India, 411 004
Pfizer Investigational Site
Delhi, New Delhi, India, 110017
Pfizer Investigational Site
Jaipur, Rajasthan, India, 302 020
Pfizer Investigational Site
Madurai, Tamil Nadu, India, 625003
Pfizer Investigational Site
Madurai, Tamil Nadu, India, 625014
Pfizer Investigational Site
Trichy, Tamil nadu, India, 620 021
Pfizer Investigational Site
Chennai, Tamilnadu, India, 600 035
Pfizer Investigational Site
Madurai, Tamilnadu, India, 625 010
Pfizer Investigational Site
Madurai, Tamilnadu, India, 625 107
Pfizer Investigational Site
Kanpur, UttarPradesh, India, 208005
Pfizer Investigational Site
Kolkata, West Bengal, India, 20 Collapse << |
NCT00872781 | Healthy | Not Applicable | Completed | - | India
... more >> Ranbaxy Clinical Pharmacology Unit
Noida,, Uttar Pradesh, India, 201 301 Collapse << |
NCT00795262 | Diabetes
Hype... more >>rtension Collapse << | Not Applicable | Completed | - | United States, Georgia
... more >>
Atlanta Vascular Research Foundation
Tucker, Georgia, United States, 30084 Collapse << |
NCT00741585 | Essential Hypertension
... more >> Cardiovascular Disease
Stroke
Chronic Kidney Disease Collapse << | Phase 4 | Completed | - | Spain
... more >> CS Friol
Friol, Lugo, Spain, 27220
CS Baiona
Baiona, Pontevedra, Spain, 36300
CS Bueu
Bueu, Pontevedra, Spain, 36930
CS A Estrada
La Estrada, Pontevedra, Spain, 26680
CS A Guarda
La Guardia, Pontevedra, Spain, 36780
CS Valmiñor
Nigran, Pontevedra, Spain, 36250
CS Panxón
Nigrán, Pontevedra, Spain, 36340
CS Tomiño
Tomiño, Pontevedra, Spain, 36200
Bioengineering & Chronobilogy Labs., University of Vigo
Vigo, Pontevedra, Spain, 36200
Hospital do Meixoeiro
Vigo, Pontevedra, Spain, 36200
CS Calle Cuba
Vigo, Pontevedra, Spain, 36202
CS A Doblada
Vigo, Pontevedra, Spain, 36205
CS Coia
Vigo, Pontevedra, Spain, 36209
CS Sardoma
Vigo, Pontevedra, Spain, 36214
CS Teis
Vigo, Pontevedra, Spain, 36216
CS Vilaboa
Vilaboa, Pontevedra, Spain, 36141
CS San Roque
Vilagarcía De Arousa, Pontevedra, Spain, 36600
CS Fingoi
Lugo, Spain, 27002
Complexo Hospitalario Universitario de Ourense
Orense, Spain, 32005
CS Lerez
Pontevedra, Spain, 36156 Collapse << |
NCT02817360 | Heart Diseases
... more >> Diabetes Mellitus, Type 2 Collapse << | Phase 4 | Recruiting | February 2021 | Austria
... more >> Internistische Ordination
Recruiting
Mödling, Niederösterreich, Austria, 2340
Contact: Christian Feinböck, MD +43 2236 869 142 office@dr-feinboeck.at
Contact: Christiane Feinböck +43 2236 869 142 office@dr-feinboeck.at
Sub-Investigator: Egbert Seyfried, MD
Principal Investigator: Christian Feinböck, MD
Klinischen Abteilung für Endokrinologie und Diabetologie MU Graz
Recruiting
Graz, Steiermark, Austria, 8036
Contact: Harald Sourij +43-316-385-80363 ha.sourij@medunigraz.at
Contact: Michael Zink +43-680-128-5120 m.zink@medunigraz.at
Sub-Investigator: Julia Mader, MD Prof
Sub-Investigator: Eva Novak, MD
Sub-Investigator: Caren Sourij, MD
Konventhospital der Barmherzigen Brüder Abteilung für Innere Medizin
Recruiting
Linz, Upper Austria, Austria, 4021
Contact: Martin Clodi, Prof.Dr. martin.clodi@bblinz.at
Principal Investigator: Martin Clodi, Prof.Dr.
Sub-Investigator: Michael Resl, Dr.
Krankenanstalt Rudolfstiftung, 1. Medizinische Abteilung
Recruiting
Vienna, Austria, 1030
Contact: Bernhard Ludvik, Prof.Dr. +43 1 711 65 ext 2107 bernhard.ludvik@wienkav.at
Principal Investigator: Bernhard Ludvik, Prof.Dr.
Sub-Investigator: Eva-Christina Krzizek, Dr.
Sub-Investigator: Johanna Brix, Dr.
Sub-Investigator: Astrid Feder, Dr.
Sub-Investigator: Florian Hoellerl, Dr.
Medical University of Vienna Univ.Clinic for Internal Medicine II Department of Cardiology
Recruiting
Vienna, Austria, 1090
Contact: Martin Huelsmann, Doz.Dr. +43 1 40400 ext 46140 martin.huelsmann@meduniwien.ac.at
Principal Investigator: Martin Huelsmann, Doz.Dr.
Sub-Investigator: Raphael Wurm, Dr.
Univ. Klinik für Innere Medizin III Med. Uni Wien
Recruiting
Vienna, Austria, 1090
Contact: Anton Luger, Prof.Dr. 00 43 1 40400 ext 43100 anton.luger@meduniwien.ac.at
Principal Investigator: Anton Luger, Prof.Dr.
Sub-Investigator: Michael Krebs, Prof.Dr.
Universitätsklinik für Augenheilkunde und Optometrie Medizinische Universität Wien
Recruiting
Vienna, Austria, 1090
Contact: Sonja Prager, Dr. +43 1 40400 ext 79470 sonja.prager@meduniwien.ac.at
Principal Investigator: Sonja Prager, Dr.
Sub-Investigator: Julia Hafner, Dr.
Diabetes & Stoffwechselambulanz Gesundheitszentrum Wien Süd
Recruiting
Vienna, Austria, 1100
Contact: Helmut Brath, OA Dr. +43 1 60122 ext 4264 helmut.brath@wgkk.at
Principal Investigator: Helmut Brath, OA Dr.
3. Med. Abtlg., KH Hietzing mit Neurologischem Zentrum Rosenhügel
Recruiting
Vienna, Austria, 1130
Contact: Rudolf Prager, Prof.Dr. +43 1 80110 ext 2351 rudolf.prager@wienkav.at
Principal Investigator: Rudolf Prager, Prof.Dr.
Sub-Investigator: Slobodan Peric, Dr.
Zentrum für Klinische Studien
Recruiting
Wien, Austria, 1060
Contact: Ursula Hanusch, MD +43 1 266 21 91 dr.hanusch@dieinternistin.com
Contact: Michaela Mauritz +43 1 266 21 91 office@dieinternistin.com
Sub-Investigator: Marita Spak, MD
Netherlands
Maastricht University Medical Center; Dep. Cardiology
Recruiting
Maastricht, Netherlands, 6202
Contact: Hans-Peter Brunner-La Rocca, MD Prof +31 43-3877097 hp.brunnerlarocca@mumc.nl
Contact: Mireille Spanjers +31 43-3877099 m.spanjers@mumc.nl
Sub-Investigator: Nick Marks, MD
Sub-Investigator: Wouter Robaeys, MD
New Zealand
Christchurch Heart Institute
Recruiting
Christchurch, New Zealand, 8140
Contact: Richard Troughton, MD Prof +64 3 364 1063 Richard.Troughton@cdhb.health.nz
Contact: Lorraine Skelton +64 3 364 1063 lorraine.skelton@cdhb@health.nz
Principal Investigator: Richard Troughton, MD Prof Collapse << |
NCT00295542 | Hypertension | Phase 4 | Completed | - | Spain
... more >> Hospital Clinico Universitario
Santiago de Compostela, Spain, 15706 Collapse << |
NCT01715584 | Hypertension | Phase 4 | Recruiting | December 31, 2019 | Canada, Ontario
... more >>
London Health Sciences Centre - Victoria Campus
Recruiting
London, Ontario, Canada, N6A 5W9
Contact: Craig J Railton, MD, PhD 519 685 8500 ext 58525 Craig.Railton@lhsc.on.ca
Principal Investigator: Craig J Railton, MD, PhD
Sub-Investigator: Jonathan Fairbairn, BSc
Sub-Investigator: George Nicoloau, MD
Sub-Investigator: Robert Gros, PhD
Sub-Investigator: Jason Franklin, MD
Sub-Investigator: John Yoo, MD
Sub-Investigator: Kevin Fung, MD
Sub-Investigator: Anthony Nichols, MD
Sub-Investigator: Danielle McNeil, MD Collapse << |
NCT00353652 | Hypertension | Phase 4 | Completed | - | United States, Texas
... more >>
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390 Collapse << |
NCT01669434 | - | - | Completed | - | - |
NCT00353652 | - | - | Completed | - | - |
NCT01867047 | Adverse Effects of Angiotensin... more >>-converting-enzyme Inhibitors
Hypotension Collapse << | Not Applicable | Terminated(Following an interi... more >>m analysis the study team felt that there was enough data that showed no significant difference.) Collapse << | - | United States, North Carolina
... more >>
Duke University
Durham, North Carolina, United States, 27710 Collapse << |
NCT00684489 | Hypertension | Not Applicable | Completed | - | - |
NCT00188188 | Systemic Lupus Erythematosus | Phase 4 | Unknown | - | Canada, Ontario
... more >>
University Health Network, Toronto Western Division
Recruiting
Toronto, Ontario, Canada, M5T 2S8
Contact: Anne Cymet, RN 416-603-5800 ext 2895 anne.cymet@uhn.on.ca
Principal Investigator: Robert M Iwanochko, MD, FRCP(C), FACC Collapse << |
NCT00159692 | Hypertension | Phase 4 | Completed | - | - |
NCT01669434 | Hypotension on Induction | Phase 4 | Completed | - | United States, Nebraska
... more >>
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198 Collapse << |
NCT01867047 | - | - | Terminated(Following an interi... more >>m analysis the study team felt that there was enough data that showed no significant difference.) Collapse << | - | - |
NCT01581476 | Type 1 Diabetes | Phase 3 | Completed | - | Australia
... more >> University of Western Australia
Perth, Australia
Canada, Ontario
Hospital for Sick Children
Toronto, Ontario, Canada Collapse << |
NCT03031834 | Diabetic Autonomic Neuropathy | Phase 4 | Completed | - | - |
NCT00154050 | Arterial Occlusive Diseases | Not Applicable | Completed | - | Germany
... more >> Chemnitz Hospital, Dept. of Internal Medicine I
Chemnitz, Germany, 09313 Collapse << |
NCT00438113 | Atrial Fibrillation | Phase 4 | Completed | - | Canada, Nova Scotia
... more >>
QE II Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3A7 Collapse << |
NCT00269243 | CABG | Phase 4 | Completed | - | - |
NCT00147524 | Menopause
Hyp... more >>ertension Collapse << | Phase 4 | Completed | - | Hungary
... more >> Pfizer Investigational Site
Hodmezovasarhely, Csongrad, Hungary
Pfizer Investigational Site
Budapest, Hungary
Pfizer Investigational Site
Mateszalka, Hungary
Pfizer Investigational Site
Szeged, Hungary
Pfizer Investigational Site
Szombathely, Hungary Collapse << |
NCT00150826 | Ischemic Heart Disease | Phase 4 | Completed | - | United States, Florida
... more >>
University of Florida
Gainesville, Florida, United States, 32610 Collapse << |
NCT00980187 | Hypertension
... more >>Type 2 Diabetes Mellitus Collapse << | Phase 4 | Completed | - | Romania
... more >> Cardiology, University and Emergency Hospital
Bucharest, Romania, 050098 Collapse << |
NCT00649649 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00313547 | Hypertension | Phase 4 | Terminated(Very difficult to r... more >>ecruit patients/slow recruitment(2 patients in nearly 2 years).) Collapse << | - | Canada, Quebec
... more >> Montreal Heart Institute
Montreal, Quebec, Canada, H1T 1C8 Collapse << |
NCT00651287 | Hypertension | Phase 4 | Completed | - | Turkey
... more >> Pfizer Investigational Site
Cerrahpasa, Istanbul, Turkey, 34300
Pfizer Investigational Site
Diyarbak R, Turkey, 21280 Collapse << |
NCT00872235 | Healthy | Not Applicable | Completed | - | India
... more >> Ranbaxy CPU
New Delhi, India, 110 062 Collapse << |
NCT00649103 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00795262 | Diabetes
Hype... more >>rtension Collapse << | Not Applicable | Completed | - | United States, Georgia
... more >>
Atlanta Vascular Research Foundation
Tucker, Georgia, United States, 30084 Collapse << |
NCT00930722 | - | - | Completed | - | India
... more >> Pfizer Investigational Site
Patna, Bihar, India, 01
Pfizer Investigational Site
Ahmedabad, Gujarat, India, 380 015
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 003
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 051
Pfizer Investigational Site
Ahmedabad, Maharashtra, India, 380 015
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440 015
Pfizer Investigational Site
Nagpur, Maharashtra, India, 440 033
Pfizer Investigational Site
Pune, Maharashtra, India, 411 004
Pfizer Investigational Site
Delhi, New Delhi, India, 110017
Pfizer Investigational Site
Jaipur, Rajasthan, India, 302 020
Pfizer Investigational Site
Madurai, Tamil Nadu, India, 625003
Pfizer Investigational Site
Madurai, Tamil Nadu, India, 625014
Pfizer Investigational Site
Trichy, Tamil nadu, India, 620 021
Pfizer Investigational Site
Chennai, Tamilnadu, India, 600 035
Pfizer Investigational Site
Madurai, Tamilnadu, India, 625 010
Pfizer Investigational Site
Madurai, Tamilnadu, India, 625 107
Pfizer Investigational Site
Kanpur, UttarPradesh, India, 208005
Pfizer Investigational Site
Kolkata, West Bengal, India, 20 Collapse << |
NCT00648011 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00649441 | Healthy | Phase 1 | Completed | - | United States, North Dakota
... more >>
PRACS Institute, Ltd.
Fargo, North Dakota, United States, 58104 Collapse << |
NCT00872781 | Healthy | Not Applicable | Completed | - | India
... more >> Ranbaxy Clinical Pharmacology Unit
Noida,, Uttar Pradesh, India, 201 301 Collapse << |
NCT00930722 | - | - | Completed | - | - |